IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 10/08/20

IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test Canada NewsWire VICTORIA, BC, Oct. 8, 2020 Also signs Definitive Commercial Agreement with University of Victoria VICTORIA, BC , Oct. 8...

IPA's CEO Dr. Jennifer Bath to Appear Live Wednesday on BNN Television Canada NewsWire VICTORIA, BC, Oct. 6, 2020 VICTORIA, BC , Oct. 6, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in fu...

ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends Canada NewsWire VICTORIA, BC, Oct. 05, 2020 VICTORIA, B...

ImmunoPrecise Antibodies (IPATF): FQ1 net loss of $549k.Revenue of $3.76M (+38.2% Y/Y)Press Release For further details see: ImmunoPrecise Antibodies reports FQ1 results

ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021 PR Newswire VICTORIA, BC, Sept. 29, 2020 VICTORIA, BC, Sept. 29, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA"...

IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg Television Canada NewsWire VICTORIA, BC, Sept. 28, 2020 VICTORIA, BC , Sept. 28, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a lead...

ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day Canada NewsWire VICTORIA, BC, Sept. 28, 2020 VICTORIA, BC , Sept. 28, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a l...

ImmunoPrecise Antibodies (IPATF) and LiteVax have initiated preclinical vaccine trials against SARS-CoV-2. Vaccine design was based on sets of data obtained during the analysis of IPA's SARS-CoV-2 therapeutic programs, and based on this, the company has designed SARS-CoV-2 spike protein ...

ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials PR Newswire VICTORIA, BC, Sept. 25, 2020 VICTORIA, BC , Sept. 25, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-s...

IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™ PR Newswire VICTORIA, BC, Sept. 22, 2020 VICTORIA, BC , Sept. 22, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE...